Australia's most trusted
source of pharma news
Posted 3 August 2022 AM
The Federal Government must fund services supporting effective cancer treatment to take maximum advantage of "22nd century" drugs being developed by the pharmaceutical sector, according to Lung Foundation Australia.
The peak body has launched a lung cancer blueprint for reform, urging the Federal Government to fund three urgent interventions to improve outcomes for people with lung cancer in Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.